Spectra7 Announces Financial Results for First Quarter 2024

Rhea-AI Summary

Spectra7 Microsystems Inc. (TSXV:SEV, OTCQB:SPVNF) announced its financial results for Q1 2024, ending March 31, 2024. Revenue was $0.8 million, up from $0.3 million in Q4 2023 but down from $3.1 million in Q1 2023. Gross margin was 41%, a decrease from 57% in Q4 2023 and 63% in Q1 2023. Non-IFRS operating expenses were $2.1 million, down from $3.5 million in Q4 2023 and $2.2 million in Q1 2023. The basic and diluted loss per share was $(0.06), improved from $(0.11) in Q4 2023 and $(0.03) in Q1 2023. EBITDA loss was $1.4 million, compared to $3.2 million in Q4 2023 and $70,000 in Q1 2023. Post Q1, the company raised C$10.7 million in new capital and eliminated C$11.7 million in convertible debt. Spectra7 aims to secure commercial orders from global data center customers for its active copper cable products in the second half of 2024.

Positive

• Revenue increased to $0.8 million from $0.3 million in Q4 2023.
• Non-IFRS operating expenses decreased to $2.1 million from $3.5 million in Q4 2023.
• Loss per share improved to $(0.06) from $(0.11) in Q4 2023.
• Eliminated C$11.7 million in convertible debt.
• Completed a non-brokered private placement for C$10.7 million in gross proceeds.

Negative

• Revenue decreased from $3.1 million in Q1 2023 to $0.8 million.
• Gross margin decreased to 41% from 63% in Q1 2023.
• EBITDA loss increased to $1.4 million compared to a loss of $70,000 in Q1 2023.
• Basic and diluted loss per share was $(0.06), higher than $(0.03) in Q1 2023.

Subsequently Closed C$10.7 Million in New Capital in May 2024

Eliminated C$11.7 Million in Convertible Debt

SAN JOSE, Calif., May 30, 2024 /PRNewswire/ -- (TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), a leader in high-performance analog semiconductors for broadband connectivity markets, such as AI networks, hyperscale data centers, and AR/VR, today announced its financial results for the three months ended March 31, 2024. A copy of the interim consolidated financial statements for the three months ended March 31, 2024, and the corresponding management's discussion and analysis (the "MD&A") will be available under the Company's profile on www.sedarplus.ca. Unless otherwise indicated, all dollar amounts in this press release are expressed in US dollars.

First quarter 2024 financial highlights

• First quarter 2024 revenue was $0.8 million, increased from $0.3 million in the fourth quarter 2023 and decreased from $3.1 million in the first quarter 2023.
  
  
• Gross margin¹ was 41%, compared to 57% in the preceding quarter and 63% in the prior year first quarter.
  
  
• Non-IFRS operating expenses² were $2.1 million, decreased from $3.5 million in the fourth quarter 2023 and $2.2 million in the first quarter 2023.
  
  
• Basic and diluted loss per share for the first quarter 2024 was $(0.06), compared with a basic and diluted loss per share of $(0.11) in the fourth quarter 2023 and $(0.03) in the first quarter 2023.
  
  
• EBITDA³ loss for the first quarter was $1.4 million, compared with an EBITDA loss of $3.2M for the fourth quarter 2023 and an EBITDA loss of $70,000 in the first quarter 2023.

Subsequent to the first quarter end, the Company completed a non-brokered private placement of units for C$10.7 million in gross proceeds. Additionally, the Company amended its C$11.7 million of existing debentures to provide the Company with the right to convert such debentures into equity securities at its option at any time prior to maturity. The Company effected the forced conversion of the debentures on May 15, 2024, effectively eliminating the Company's long-term debt.

Spectra7 remains focused on advancing to commercial orders from top global datacenter customers for its active copper cable products, expected in the second half of 2024.⁴

"We are pleased to have strengthened our balance sheet and eliminated our long term debt in support of our growth plans," said Raouf Halim, Chief Executive Officer.

NOTES:

¹ Gross margin is a non-GAAP measure which is computed as revenue less cost of sales divided by revenue. Refer to "Revenue and Gross Margin" in the MD&A and the table below, for reconciliation to measures reported in the Company's interim financial statements. 

The table below sets forth the details of revenue and gross margin for the three months ended March 31, 2024 and March 31, 2023.

	Three Months Ended March 31,
	(In thousands)
	2024		2023		Change
	$		$		$	%
Revenue	816		3,134		(2,318)	(74 %)
Cost of sales	483		1,172		(689)	(59 %)
Gross profit	333		1,963		(1,629)	(83 %)
Gross margin %	41 %		63 %		(22 %)

 

² Non-IFRS operating expenses is a non-GAAP measure which includes research and development, sales and marketing, general and administrative expenses and depreciation and amortization for capital equipment and right-of-use assets and excludes share-based compensation expense, non-recurring termination costs, interest and related financing costs, change in fair value of warrant liabilities, foreign exchange gain/loss and gain/loss from property and equipment disposal. Refer to "Non-GAAP Measures" in the MD&A and the table below for reconciliation to measures reported in the Company's interim financial statements.

		in thousands
		2022				2023					2024
		Jun 30	Sep 30	Dec 31		Mar 31	Jun 30	Sep 30	Dec 31		Mar 31
		$	$	$		$	$	$	$		$
Total expenses - IFRS		3,331	2,936	3,210		3,053	3,330	3,086	4,479		2,575
Share‑based compensation		646	567	469		541	486	288	334		182
Interest on lease obligation of right-of-use assets		5	4	3		1	4	4	3		1
Accretion expense		389	463	425		370	389	411	493		538
Other income		(12)	-	-		-	(12)	(30)	(9)		-
Foreign exchange gain		57	(9)	354		(72)	57	(110)	143		(211)
Non-IFRS operating expenses		2,246	1,911	1,959		2,212	2,407	2,523	3,515		2,065
		in thousands
		2022				2023					2024
		Jun 30	Sep 30	Dec 31		Mar 31	Jun 30	Sep 30	Dec 31		Mar 31
		$	$	$		$	$	$	$		$
Research and development, net of investment tax credits and including amortization of licenses		1,158	985	928		995	1,195	1,409	1,154		1,040
Sales and marketing		258	224	280		269	252	271	325		279
General and administrative		875	635	684		881	891	762	1,947		657
Depreciation of right-of-use assets		113	60	60		60	60	60	60		60
Depreciation of property and equipment		10	7	8		8	8	21	28		28
Non-IFRS operating expenses		2,414	1,911	1,959		2,212	2,407	2,523	3,515		2,065

 

³ EBITDA or earnings before interest, tax, depreciation, and amortization is a non-GAAP measure. EBITDA excludes share-based compensation, amortization, depreciation, interest, and tax expenses. Refer to "Non-GAAP Measures" in the MD&A and the table below for reconciliation to measures reported in the Company's interim financial statements. 

		in thousands
		2022				2023					2024
		Jun 30	Sep 30	Dec 31		Mar 31	Jun 30	Sep 30	Dec 31		Mar 31
		$	$	$		$	$	$	$		$
Net loss		(1,586)	(1,461)	(1,231)		(1,090)	(1,275)	(1,500)	(4,315)		(2,242)
Depreciation of right-of-use assets		113	60	60		60	60	60	60		60
Depreciation of property and equipment		10	7	8		8	8	21	28		28
Depreciation expense - COGS		18	31	35		35	30	31	31		32
Amortization - intangible assets		145	137	55		76	105	90	179		167
Share-based compensation		646	567	469		541	486	288	334		182
Interest on lease obligation of right-of-use assets		5	4	3		1	4	4	3		1
Accretion expense		232	463	425		370	389	411	493		538
Other income		-	-	-		-	(12)	(30)	(9)		-
Foreign Tax		-	-	(216)		-	-	-	(119)		-
Foreign exchange gain		34	(9)	354		(72)	57	(110)	143		(211)
Extingushment of original convertible debt		-	-	-		-	-	-	-		-
Other income		(217)	-	-		-	-	-	-		-
EBITDA		(600)	(201)	(38)		(70)	(148)	(734)	(3,172)		(1,445)

 

⁴ This is forward-looking information and is based on a number of assumptions. See "Cautionary Notes," below.

ABOUT SPECTRA7 MICROSYSTEMS INC.

Spectra7 Microsystems Inc. is a high-performance analog semiconductor company delivering unprecedented bandwidth, speed and resolution to enable disruptive industrial design for leading electronics manufacturers in virtual reality, augmented reality, mixed reality, data centers and other connectivity markets. Spectra7 is based in San Jose, California with a design center in Cork, Ireland and a technical support location in Dongguan, China. For more information, please visit www.spectra7.com. 

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY NOTES

Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, the Company's anticipated increase in commercial orders in the second half of 2024 for its datacenter products, which is dependent on the success of various sampling efforts currently underway; and the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to, the risk factors discussed in the Company's management's discussion and analysis for the year ended December 31, 2023. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.

For more information, please contact:

Matt Kreps, Managing Director
Darrow Associates Investor Relations
mkreps@darrowir.com
214-597-8200

Spectra7 Microsystems Inc.
Dave Mier
Interim Chief Financial Officer
925-858-7011
ir@spectra7.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/spectra7-announces-financial-results-for-first-quarter-2024-302159933.html

SOURCE Spectra7 Microsystems Inc.

FAQ

What were Spectra7's Q1 2024 revenue results?

Spectra7 reported Q1 2024 revenue of $0.8 million, an increase from $0.3 million in Q4 2023 but a decrease from $3.1 million in Q1 2023.

What is the gross margin for Spectra7 in Q1 2024?

The gross margin for Spectra7 in Q1 2024 was 41%, down from 57% in Q4 2023 and 63% in Q1 2023.

How did Spectra7's operating expenses change in Q1 2024?

Spectra7's non-IFRS operating expenses decreased to $2.1 million in Q1 2024 from $3.5 million in Q4 2023 and $2.2 million in Q1 2023.

What was Spectra7's loss per share in Q1 2024?

Spectra7's basic and diluted loss per share in Q1 2024 was $(0.06), an improvement from $(0.11) in Q4 2023 but higher than $(0.03) in Q1 2023.

How did Spectra7's EBITDA change in Q1 2024?

Spectra7 reported an EBITDA loss of $1.4 million in Q1 2024, compared to a loss of $3.2 million in Q4 2023 and $70,000 in Q1 2023.

What capital actions did Spectra7 take after Q1 2024?

After Q1 2024, Spectra7 completed a non-brokered private placement for C$10.7 million and eliminated C$11.7 million in convertible debt.